Early research (Phase 1)Study completedNCT01760525
What this trial is testing
A Phase I Dose Escalation Study of CGM097 in Adult Patients With Selected Advanced Solid Tumors
Who this might be right for
Solid Tumor With p53 Wild Type Status
Novartis Pharmaceuticals 51